161 related articles for article (PubMed ID: 6212169)
1. Degradation of keratan sulfate by beta-N-acetylhexosaminidases in GM2-gangliosidosis.
Yutaka T; Okada S; Kato T; Yabuuhi H
Clin Genet; 1982 Mar; 21(3):196-202. PubMed ID: 6212169
[TBL] [Abstract][Full Text] [Related]
2. Impaired degradation of chondroitin sulfate in GM2-gangliosidosis.
Yutaka T; Kato T; Okada S; Yabuuci H
Clin Genet; 1982 Oct; 22(4):165-71. PubMed ID: 6217929
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of the (1 goes to 3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl linkage present in keratan sulfate. The A and B isoenzymes of human liver hexosaminidase (EC 3.2.1.30).
Toma S; Coppa G; Donnelly PV; Ricci R; Di Ferrante N; Srivastava SK
Carbohydr Res; 1981 Oct; 96(2):271-90. PubMed ID: 6458358
[TBL] [Abstract][Full Text] [Related]
4. Degradation of keratan sulphate by beta-N-acetylhexosaminidases A and B.
Ludolph T; Paschke E; Glössl J; Kresse H
Biochem J; 1981 Mar; 193(3):811-8. PubMed ID: 6458277
[TBL] [Abstract][Full Text] [Related]
5. Liberation of N-acetylglucosamine-6-sulfate by human beta-N-acetylhexosaminidase A.
Kresse H; Fuchs W; Glössl J; Holtfrerich D; Gilberg W
J Biol Chem; 1981 Dec; 256(24):12926-32. PubMed ID: 6458607
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of Tay-Sachs disease by estimation of beta-N-acetylhexosaminidase activity using a radiolabeled hyaluronic acid-derived trisaccharide substrate.
Yutaka T; Kato T; Midorikawa M; Doke M; Okada S; Yabuuchi H
Clin Chim Acta; 1984 Feb; 137(2):159-68. PubMed ID: 6231138
[TBL] [Abstract][Full Text] [Related]
7. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
Harzer K
Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
[No Abstract] [Full Text] [Related]
8. Chromatofocusing coupled with automated assay for beta-hexosaminidase isoenzymes in GM2 gangliosidosis.
Orlacchio A; Maffei C; Emiliani C; Coppa GV; Felici L
Experientia; 1985 Apr; 41(4):525-7. PubMed ID: 3157597
[TBL] [Abstract][Full Text] [Related]
9. Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta.
Akeboshi H; Chiba Y; Kasahara Y; Takashiba M; Takaoka Y; Ohsawa M; Tajima Y; Kawashima I; Tsuji D; Itoh K; Sakuraba H; Jigami Y
Appl Environ Microbiol; 2007 Aug; 73(15):4805-12. PubMed ID: 17557860
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
Poulos A; Holding J; Carey WF
Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
[TBL] [Abstract][Full Text] [Related]
11. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
Christopher R; Rangaswamy GR; Shetty KT
Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
[TBL] [Abstract][Full Text] [Related]
12. The biochemical basis of gangliosidoses.
Sandhoff K; Conzelmann E
Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
[No Abstract] [Full Text] [Related]
13. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
Bayleran J; Hechtman P; Saray W
Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
[TBL] [Abstract][Full Text] [Related]
14. Preparation from keratin sulfate of substrates for the measurement of 2-acetamido-2-deoxy-D-glucose 6-sulfate sulfatase and (1 goes to 3)-N-acetyl-beta-D-glucosaminidase.
Toma S; Di Ferrante DT; Tenni R; Di Ferrante N
Carbohydr Res; 1981 Jan; 88(1):93-105. PubMed ID: 6451291
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
[TBL] [Abstract][Full Text] [Related]
16. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
[TBL] [Abstract][Full Text] [Related]
17. GM2-gangliosidosis. Clinical and biochemical aspects of four cases.
Praamstra P; Wevers RA; Gabreëls FJ; Rotteveel JJ; Renier WO; Sengers RC; Lamers KJ
Clin Neurol Neurosurg; 1990; 92(2):143-8. PubMed ID: 2163796
[TBL] [Abstract][Full Text] [Related]
18. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
19. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
Conzelmann E; Kytzia HJ; Navon R; Sandhoff K
Am J Hum Genet; 1983 Sep; 35(5):900-13. PubMed ID: 6614006
[TBL] [Abstract][Full Text] [Related]
20. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
Raghavan SS; Krusell A; Krusell J; Lyerla TA; Kolodny EH
Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]